ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Winter Conference & Expo
November 15–18, 2026
Phoenix, AZ|Arizona Grand Resort & Spa
Latest Magazine Issues
Sep 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
October 2026
Nuclear Technology
Fusion Science and Technology
Latest News
Westinghouse, Nordion, and PSEG team up to produce Co‑60 in the United States
This past January, Westinghouse Electric Company, Nordion, and PSEG Nuclear formalized agreements to implement newly developed cobalt-60 production technology at Units 1 and 2 of PSEG’s Salem nuclear power plant in New Jersey, with the Co-60 to be supplied to Nordion. Through an ongoing joint initiative, the companies aim to harness U.S. pressurized water reactors to produce a key medical isotope and build the first commercial-scale Co-60 production platform in the United States.
Y. Ikeda, E. T. Cheng, C. Konno, H. Maekawa
Nuclear Science and Engineering | Volume 116 | Number 1 | January 1994 | Pages 28-34
Technical Paper | doi.org/10.13182/NSE94-A21478
Articles are hosted by Taylor and Francis Online.
The activation cross sections for the 99Tc(n,p)99Mo, 99Tc(n,α)96Nb, 99Tc(n,n′α)95Nb, and“Tc(n,n′)99mTc reactions at 13.5 and 14.8 MeV have been measured by using the deuterium-tritium neutron generator (the Fusion Neutronics Source) at the Japan Atomic Energy Research Institute. The results were compared with experimental values from the literature, evaluated activation cross-section files, and predictions by current cross-section computer codes. Special emphasis was placed on the feasibility of producing high-specific-activity“Mo, to be used in medical applications, via the 99Tc(n,p)99Mo reaction in the Fusion Material Irradiation Facility. A factor of 3 overestimate of 99Mo production resulted when the REAC *2 code was used. It is suggested that this discrepancy is due primarily to the factor of 5 difference in cross sections at the 14-MeV region between the REAC*2 data and the current measurement.